Skip to main content
Simulations Plus, Inc. logo

Simulations Plus, Inc. — Investor Relations & Filings

Ticker · SLP ISIN · US8292141053 LEI · 529900KYRDJAQ8TJCG93 US Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Filings indexed 1,013 across all filing types
Latest filing 2025-04-01 Regulatory Filings
Country US United States of America
Listing US SLP

About Simulations Plus, Inc.

https://www.simulations-plus.com/

Simulations Plus, Inc. is a leading provider of modeling and simulation software and consulting services for the pharmaceutical, biotechnology, and chemical industries. The company develops solutions that support drug discovery, development research, and regulatory submissions. Its offerings utilize advanced technologies such as AI/machine learning, physiologically based pharmacokinetic (PBPK), quantitative systems pharmacology (QSP), and quantitative systems toxicology (QST) modeling. Key software products, including GastroPlus®, ADMET Predictor®, and the MonolixSuite™, are used by researchers to predict the behavior, safety, and efficacy of drug candidates. These tools are designed to accelerate the development process, reduce research and development costs, and support critical advancements in healthcare.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2025
Regulatory Filings
2025-04-01 English
FORM 4
Director's Dealing
2025-03-04 English
8-K
Regulatory Filings
2025-02-18 English
FORM 4
Director's Dealing
2025-02-04 English
FORM 4
Director's Dealing
2025-02-04 English
FORM 4
Director's Dealing
2025-02-04 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.